DaVita Inc.DVA
Health Care · Health Care Equipment & Services · NYSE · United States · davita.com
DaVita Inc. is a leading provider of kidney care services in the United States and internationally, operating a large network of dialysis centers and outpatient kidney disease clinics. The company provides dialysis services and related laboratory and ancillary services to patients with chronic kidney failure (end stage renal disease). DaVita is headquartered in Denver, Colorado.
Key ratios
Operating cash flow growth
17.8%TTM
2025
-6.7%2024
-1.8%2023
31.6%
EPS growth
15.2%TTM
2025
-11.4%2024
44.6%2023
30.0%
FCF / Sales
11.5%TTM
2025
9.6%2024
11.4%2023
12.3%
Net margin
6.1%TTM
2025
5.5%2024
7.3%2023
5.7%
ROA
7.5%TTM
2025
7.3%2024
7.2%2023
5.9%
ROE
64.9%TTM
2025
64.9%2024
51.7%2023
38.5%
Revenue growth
6.5%TTM
2025
6.5%2024
5.6%2023
4.6%
Recent news
DaVita Sets Bold 2030 Community Care Commitments After Exceeding Prior Five-Year ESG Goals
DaVita Inc. 1st Quarter 2026 Results
Track DVA in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer